Advair Relaunch And Nasal Naloxone Nod Raise Hikma’s Expectations

Also Strikes Branded Injectables Deal With Melinta For MENA Region

 
• By David Wallace
Dial Gauge High
Hikma expects its generics business to hit the top end of its 2021 forecast • Source: Alamy

More from Earnings

More from Business